Tumala, Apolinaria A.

HRN: 26-76-31  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/28/2025
AZITHROMYCIN 500MG TABLET (TAB)
02/28/2025
03/05/2025
PO
500mg
OD
CAP
Waiting Final Action 
02/28/2025
CEFTAZIDIME 1GM (VIAL)
02/28/2025
03/07/2025
IVTT
1g
Q8H
CAP
Waiting Final Action 
03/08/2025
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
03/08/2025
03/14/2025
IVTT
500 Mg
Q8
Intra Abdominal Infection;
Waiting Final Action 
03/08/2025
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
03/08/2025
03/15/2025
IV
4.5gm
Q6H
Elevated WBC 28
Waiting Final Action 
03/15/2025
MUPIROCIN 2%, 15G (TUBE)
03/15/2025
03/22/2025
TOPICAL
Pea-size
BID
Sacral Ulcer
Waiting Final Action 
03/17/2025
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
03/17/2025
03/24/2025
IVT
4.5g
Q8
CAP
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: